These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3628969)
21. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors. Hadizadeh F; Ghodsi R Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243 [TBL] [Abstract][Full Text] [Related]
23. Psychopharmacological effects of melatonin in mouse and rat. Sugden D J Pharmacol Exp Ther; 1983 Dec; 227(3):587-91. PubMed ID: 6655558 [TBL] [Abstract][Full Text] [Related]
24. Correlation between anticonvulsant activity & monoamine oxidase inhibitory & antihemolytic properties of some guanidines. Raman K; Pandey BR; Barthwal JP; Parmar SS Indian J Exp Biol; 1979 Oct; 17(10):1116-8. PubMed ID: 546748 [No Abstract] [Full Text] [Related]
25. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835 [TBL] [Abstract][Full Text] [Related]
26. [Durene derivates. IV. N-((2,3,5,6-tetramethylbenzoyl)alkyl)imidazoles and N-((beta-(2,3,5,6-tetramethylphenyl)-beta-hydroxy)ethyl)imidazoles with anticonvulsant activity]. Leonardi A; Motta G; Subissi A; Nardi D Farmaco Sci; 1981 Aug; 36(8):711-20. PubMed ID: 7274447 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Hassan SY; Khattab SN; Bekhit AA; Amer A Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and preliminary anticonvulsant activity evaluation of new 2-thioxo-4,5-imidazolidinedione derivatives. Ulusoy N; Ozkirimli S; Gürsu E Boll Chim Farm; 1999 Nov; 138(10):516-20. PubMed ID: 10765468 [TBL] [Abstract][Full Text] [Related]
29. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035 [TBL] [Abstract][Full Text] [Related]
30. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. Yunger LM; Fowler PJ; Zarevics P; Setler PE J Pharmacol Exp Ther; 1984 Jan; 228(1):109-15. PubMed ID: 6694095 [TBL] [Abstract][Full Text] [Related]
32. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological properties of some aminoalkanolic derivatives of xanthone. Marona H; Pekala E; Filipek B; Maciag D; Szneler E Pharmazie; 2001 Jul; 56(7):567-72. PubMed ID: 11487977 [TBL] [Abstract][Full Text] [Related]
36. Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile. Graziani G; Tirone F; Barbadoro E; Testa R Arzneimittelforschung; 1983; 33(8):1155-60. PubMed ID: 6685493 [TBL] [Abstract][Full Text] [Related]
37. Correlation between monoamine oxidase inhibitors and anticonvulsants. Dwivedi C; Misra RS; Chaudhari A; Parmar SS J Natl Med Assoc; 1980 Oct; 72(10):953-5. PubMed ID: 7420438 [TBL] [Abstract][Full Text] [Related]
38. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM; Du GH Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097 [TBL] [Abstract][Full Text] [Related]
39. [Studies on the monoamine oxidase inhibiting properties of imidazole derivatives]. Winter R Acta Biol Med Ger; 1973; 30(4):555-61. PubMed ID: 4146878 [No Abstract] [Full Text] [Related]
40. Search for possible CNS depressant compounds: Part II. Synthesis of some new 1-(2'-methoxy-4'-nitrophenyl)-2-phenyl-4-substituted arylidene-5-imidazolones as CNS depressants. Mukerji DD; Nautiyal SR; Prasad CR Pol J Pharmacol Pharm; 1981; 33(6):633-7. PubMed ID: 7347813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]